Skip to content
Insights

2026-06-14

Medical Device Cybersecurity & the FDA

Cybersecurity is now a gating requirement for FDA clearance of connected devices. What 'cyber device' means under section 524B, the SBOM requirement, and what FDA expects pre- and post-market.

Cybersecurity is no longer a nice-to-have appended to a submission, for connected medical devices it is a gating requirement for FDA clearance, and an ongoing post-market obligation.

”Cyber devices” and section 524B

Under section 524B of the Food, Drug, and Cosmetic Act, sponsors of a cyber device (broadly, a device with software that can connect to the internet and could be vulnerable to threats) must include cybersecurity information in their premarket submission. FDA can refuse to accept a submission that does not adequately address it. At minimum, sponsors must:

Pre-market: build security into design

FDA expects security to be engineered in, not bolted on:

Post-market: the work continues

Clearance is the start, not the finish. Post-market expectations include vulnerability monitoring, coordinated disclosure procedures, patch and update management, and documentation that keeps the device’s regulatory file current as the threat landscape changes.

Why it matters

Connected devices touch protected health information and clinical workflows. A credible cybersecurity program protects patients, satisfies FDA, and increasingly satisfies hospital procurement and HIPAA obligations at the same time, turning a compliance burden into a trust advantage.


Sequence Group builds medical-device cybersecurity programs, threat modeling, SBOM, security risk management, and pre/post-market documentation, alongside HIPAA compliance. Get in touch.

Need a regulatory or quality partner?

Get in touch